HYREZTIQ Trademark

Trademark Overview

On Wednesday, June 5, 2013, a trademark application was filed for HYREZTIQ with the United States Patent and Trademark Office. The USPTO has given the HYREZTIQ trademark a serial number of 85951392. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 16, 2017. This trademark is owned by Pfizer Inc.. The HYREZTIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
hyreztiq

General Information

Serial Number85951392
Word MarkHYREZTIQ
Filing DateWednesday, June 5, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 16, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 14, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, January 17, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 16, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 28, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 25, 2016EXTENSION 5 GRANTED
Wednesday, May 18, 2016EXTENSION 5 FILED
Wednesday, May 18, 2016TEAS EXTENSION RECEIVED
Tuesday, January 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 16, 2016EXTENSION 4 GRANTED
Thursday, December 3, 2015EXTENSION 4 FILED
Wednesday, January 6, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 3, 2015TEAS EXTENSION RECEIVED
Thursday, December 3, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 3, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 9, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 6, 2015EXTENSION 3 GRANTED
Wednesday, May 6, 2015EXTENSION 3 FILED
Friday, June 5, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 6, 2015TEAS EXTENSION RECEIVED
Tuesday, November 18, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 14, 2014EXTENSION 2 GRANTED
Friday, November 14, 2014EXTENSION 2 FILED
Friday, November 14, 2014TEAS EXTENSION RECEIVED
Friday, May 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 21, 2014EXTENSION 1 GRANTED
Wednesday, May 21, 2014EXTENSION 1 FILED
Wednesday, May 21, 2014TEAS EXTENSION RECEIVED
Tuesday, December 10, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 15, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2013PUBLISHED FOR OPPOSITION
Wednesday, September 25, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 3, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 29, 2013ASSIGNED TO EXAMINER
Friday, June 14, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 8, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

hyreztiq preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases